Inventor · disambiguated record
Ton Logtenberg
Also filed as: LOGTENBERG TON · LOGTENBERG TON N
56 granted patents·36 pending applications·1,896 citations·filing 1998–2025
99Inventor score
Top patents by PatentIndex Score
92 records- 0198US9358286B2Methods and means for the production of IG-like moleculesMERUS B V·Filed 2013·Granted Jun 7, 2016·100 cites·32 claims
- 0298US9248182B2Methods and means for the production of Ig-like moleculesMERUS B V·Filed 2013·Granted Feb 2, 2016·73 cites·40 claims
- 0398US9248181B2Methods and means for the production of Ig-like moleculesMERUS B V·Filed 2013·Granted Feb 2, 2016·95 cites·37 claims
- 0498US7932360B2Recombinant production of mixtures of antibodiesMERUS B V·Filed 2006·Granted Apr 26, 2011·41 cites·17 claims
- 0598US7429486B2Recombinant production of mixtures of antibodiesCRUCELL HOLLAND BV·Filed 2006·Granted Sep 30, 2008·82 cites·20 claims
- 0698US7262028B2Recombinant production of mixtures of antibodiesCRUCELL HOLLAND BV·Filed 2005·Granted Aug 28, 2007·245 cites·20 claims
- 0798US6265150B1Phage antibodiesBECTON DICKINSON CO·Filed 1998·Granted Jul 24, 2001·678 cites·8 claims
- 0897US11926859B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2023·Granted Mar 12, 2024·2 cites·7 claims
- 0997US9758805B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2015·Granted Sep 12, 2017·23 cites·43 claims
- 1097US7927834B2Recombinant production of mixtures of antibodiesMERUS B V·Filed 2008·Granted Apr 19, 2011·42 cites·23 claims
- 1197US7919257B2Method for selecting a single cell expressing a heterogeneous combination of antibodiesMERUS BIOPHARMACEUTICALS B V I O·Filed 2005·Granted Apr 5, 2011·110 cites·13 claims
- 1296US12139548B2Antibody that binds ErbB-2 and ErbB-3MERUS NV·Filed 2022·Granted Nov 12, 2024·4 cites·20 claims
- 1395US12247078B2ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion geneMERUS NV·Filed 2024·Granted Mar 11, 2025·3 cites·20 claims
- 1495US10605808B2Antibody producing non-human animalsMERUS NV·Filed 2016·Granted Mar 31, 2020·19 cites·9 claims
- 1595US9765133B2Antibody producing non-human mammalsMERUS B V·Filed 2014·Granted Sep 19, 2017·12 cites·5 claims
- 1695US9145588B2Generation of binding moleculesMERUS B V·Filed 2012·Granted Sep 29, 2015·69 cites·10 claims
- 1795US8268756B2Mixture of binding proteinsLOGTENBERG TON·Filed 2006·Granted Sep 18, 2012·36 cites·8 claims
- 1895US7901919B2Chimaeric phagesCRUCELL HOLLAND BV·Filed 2007·Granted Mar 8, 2011·26 cites·8 claims
- 1994US11237165B2Antibody producing non-human animalsMERUS NV·Filed 2017·Granted Feb 1, 2022·5 cites·14 claims
- 2094US10752929B2Methods and means for the production of ig-like moleculesMERUS NV·Filed 2019·Granted Aug 25, 2020·5 cites·15 claims
- 2194US10670599B2Method for selecting a single cell expressing a heterogeneous combination of antibodiesMERUS NV·Filed 2017·Granted Jun 2, 2020·6 cites·13 claims
- 2294US9944695B2Antibody producing non-human mammalsMERUS B V·Filed 2014·Granted Apr 17, 2018·8 cites·3 claims
- 2394US9012371B2Mixtures of binding proteinsLOGTENBERG TON·Filed 2011·Granted Apr 21, 2015·18 cites·14 claims
- 2493US10934571B2Recombinant production of mixtures of antibodiesMERUS NV·Filed 2016·Granted Mar 2, 2021·4 cites·20 claims
- 2593US9951124B2Antibody producing non-human mammalsMERUS NV·Filed 2013·Granted Apr 24, 2018·10 cites·4 claims
- 2693US7777010B2Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitopeCRUCELL HOLLAND BV·Filed 2002·Granted Aug 17, 2010·29 cites·20 claims
- 2792US10844127B2Antibodies that bind EGFR and ErbB3MERUS NV·Filed 2015·Granted Nov 24, 2020·8 cites·18 claims
- 2892US10647781B2Generation of binding moleculesMERUS NV·Filed 2017·Granted May 12, 2020·6 cites·7 claims
- 2992US6858384B2Phage antibodiesCRUCELL HOLLAND BV·Filed 2001·Granted Feb 22, 2005·25 cites·7 claims
- 3091US11820825B2Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumorMERUS NV·Filed 2020·Granted Nov 21, 2023·2 cites·12 claims
- 3191US11408095B2Generation of binding moleculesMERUS NV·Filed 2020·Granted Aug 9, 2022·2 cites·7 claims
- 3291US9908946B2Generation of binding moleculesMERUS B V·Filed 2015·Granted Mar 6, 2018·6 cites·7 claims
- 3390US11279770B2Antibody that binds ErbB-2 and ErbB-3MERUS NV·Filed 2015·Granted Mar 22, 2022·7 cites·17 claims
- 3490US2024344102A1Methods and means for the production of ig-like moleculesMERUS NV·Filed 2024·Application pending·0 cites
- 3589US11559049B2Antibody producing non-human animalsMERUS NV·Filed 2018·Granted Jan 24, 2023·2 cites·7 claims
- 3689US10358492B2Bispecific IgG antibodies as T cell engagersMERUS NV·Filed 2013·Granted Jul 23, 2019·11 cites·30 claims
- 3788US12123043B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2020·Granted Oct 22, 2024·1 cites·26 claims
- 3888US10329596B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2016·Granted Jun 25, 2019·4 cites·34 claims
- 3988US7329530B2Chimaeric phagesCRUCELL HOLLAND BV·Filed 2002·Granted Feb 12, 2008·33 cites·13 claims
- 4088US2024164354A1Antibody producing non-human animalsMERUS B V·Filed 2024·Application pending·0 cites
- 4187US11732043B2Antibodies that modulate a biological activity expressed by a cellMERUS NV·Filed 2018·Granted Aug 22, 2023·3 cites·22 claims
- 4287US10337045B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2017·Granted Jul 2, 2019·3 cites·56 claims
- 4387US2024023527A1Antibody producing non-human animalsMERUS NV·Filed 2023·Application pending·0 cites
- 4487US2024156072A1Antibody producing non-human animalsMERUS NV·Filed 2023·Application pending·0 cites
- 4586US11780925B2ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion geneMERUS NV·Filed 2018·Granted Oct 10, 2023·5 cites·15 claims
- 4686US10966411B2Antibody producing non-human mammalsLOGTENBERG TON·Filed 2009·Granted Apr 6, 2021·3 cites·14 claims
- 4786US9738701B2Method for selecting a single cell expressing a heterogeneous combination of antibodiesHOOGENBOOM HENDRICUS RENERUS·Filed 2011·Granted Aug 22, 2017·10 cites·32 claims
- 4885US11667714B2Binding molecules that modulate a biological activity expressed by a cellMERUS NV·Filed 2018·Granted Jun 6, 2023·3 cites·48 claims
- 4984US9303081B2Recombinant production of mixtures of antibodiesVAN BERKEL PATRICIUS H C·Filed 2011·Granted Apr 5, 2016·6 cites·14 claims
- 5083US2024158532A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2024·Application pending·0 cites
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ton Logtenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →